Bendectin and birth defects : the challenges of mass toxic substances litigation /
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabi...
Call Number: | Libro Electrónico |
---|---|
Main Author: | |
Format: | Electronic eBook |
Language: | Inglés |
Published: |
Philadelphia :
University of Pennsylvania Press,
©1996.
|
Subjects: | |
Online Access: | Texto completo |